Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor

American Journal of Obstetrics and Gynecology

Volumn 183, Issue 4, 2000, Pages 956-963

  Gossmann, Axel ^a,b   Helbich, Thomas H ^a,b   Mesiano, Sam ^a,b   Shames, David M ^a,b   Wendland, Michael F ^a,b   Roberts, Timothy P L ^a,b   Ferrara, Napleone ^a,b   Jaffe, Robert B ^a,b   Brasch, Robert C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GENENTECH INC   (United States)

Author keywords

Angiogenesis inhibition; Ascites; Magnetic resonance imaging; Ovarian cancer; Rat model

Indexed keywords

GADOLINIUM PENTETATE ALBUMIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ASCITES; BLOOD VESSEL PERMEABILITY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HUMAN; HUMAN CELL; MICROVASCULATURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; OVARY CANCER; PRIORITY JOURNAL; RAT;

EID: 0033784641     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.107092     Document Type: Conference Paper

References (21)

1. Cancer statistics, 1995
2. Annual report on the results of treatment of gynecologic cancer
3. Vascular endothelial growth factor: Basic biology and clinical implications
4. Exchange of macromolecules between plasma and peritoneal cavity in ascites tumor-bearing, normal, and serotonin-injected mice
5. Pathogenesis of ascites tumor growth: Angiogenesis, vascular remodeling, and stroma formation in the peritoneal lining
6. Tumor angiogenesis in advanced stage ovarian carcinoma
7. Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor
8. Assessing tumor angiogenesis using macromolecular MR imaging contrast media
9. Role of vascular endothelial growth factor in ovarian cancer: Inhibition of ascites formation by immunoneutralization
10. Albumin labeled with Gd-DTPA: An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: Preparation and characterization
11. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media
12. Transport of molecules across tumor vasculature
13. Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media
14. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents
15. MS-325: Albumin-targeted contrast agent for MR angiography
16. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns
17. 30 for microvessel characterization in an intracranial glioma model
18. Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumors in rats by using three MR contrast agents
19. Dynamic breast MR imaging: Are signal intensity time course data useful for differential diagnosis of enhancing lesions?
20. Barriers to drug delivery in solid tumors
21. Microvascular permeability of normal and neoplastic tissues